Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ALKERMES RG (NQ: ALKS)
49.47 USD  -1.11 (-2.19%)
Official Closing Price  /  Updated: 8:10 PM EDT, Oct 23, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,132,353
Open 50.58
Bid (Size) 28.00 (100)
Ask (Size) 52.48 (200)
Prev. Close 50.58
Today's Range 49.40 - 50.58
52wk Range 48.90 - 63.40
Shares Outstanding 145,827,889
Dividend Yield N/A
Performance
YTD
-11.82%
-11.82%
1 Month
-4.46%
-4.46%
3 Month
-15.62%
-15.62%
6 Month
-12.80%
-12.80%
1 Year
-12.74%
-12.74%
Top News
More News
Stock Performance Review on Drug Delivery Industry -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma
from PR Newswire
Alkermes to Host Conference Call to Discuss Third Quarter 2017 Financial Results
Alkermes plc (NASDAQ: ALKS) will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m. BST) on Thursday, Oct. 26, 2017, to discuss the company’s third quarter 2017 financial... Read More
from Business Wire News Releases
More News
Read More
New Study Comparing Effectiveness of Extended-Release Naltrexone to Buprenorphine-Naloxone for Opioid Dependence Published in JAMA Psychiatry
from Business Wire News Releases
Alkermes to Present New Clinical Data on ALKS 8700 at MSParis2017, the 7th Joint ECTRIMS-ACTRIMS Meeting
from Business Wire News Releases
Alkermes Participates in President’s Commission Meeting on Combating Drug Addiction and the Opioid Crisis
from Business Wire News Releases
Patients Switched to Alkermes’ ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After Inadequate Response or Intolerance to INVEGA SUSTENNA®
from Business Wire News Releases
Add Up The Parts: FBT Could Be Worth $142
category ETFs
from ETF Channel
Alkermes Announces 2nd Annual Competitive Grants Program to Support Those Affected by Mental Health and Substance Use Disorders
from Business Wire News Releases
Alkermes to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
from Business Wire News Releases
Alkermes to Present Clinical and Real-World Data at Upcoming 30th Annual Psych Congress
from Business Wire News Releases
Implied BBH Analyst Target Price: $150
category ETFs
from ETF Channel
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial